| Literature DB >> 30903920 |
Wendi Xiao1, Xiaoqing Chen2, Lisa Liu1, Yuansen Shu1, Min Zhang3, Yucheng Zhong4.
Abstract
Protein arginine methyltransferases (PRMTs) play important roles in protein methylation. PRMT5 is the major type II arginine methyltransferase that catalyzes the transfer of two methyl groups symmetrically to the arginine residues of either histone or non-histone proteins. In recent years, increasing evidence has shown that PRMT5, as an oncogene, plays an indispensable regulatory role in the pathological progression of several human cancers by promoting the proliferation, invasion, and migration of cancer cells. PRMT5 is overexpressed in many malignant tumors and plays an important role in the occurrence and development of cancer, which suggests that PRMT5 may become a potential biomarker or therapeutic target of cancer. This article reviews the biological function, mechanism, and clinical significance of PRMT5 in tumorigenesis.Entities:
Keywords: Biomarker; Cancer; Oncogene; PRMT5
Mesh:
Substances:
Year: 2019 PMID: 30903920 DOI: 10.1016/j.biopha.2019.108790
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529